AKBA logo

AKBA

Akebia Therapeutics, Inc.NASDAQHealthcare
$1.38-2.13%ClosedMarket Cap: $369.7M

As of 2026-04-06

Insider Statistics (Q2 2026)

Purchases

1

Sales

0

Buy/Sell Ratio

0.00

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Apr 03Vickers Philip J.directorSell214,400$1.41214,400
Fri Apr 03Vickers Philip J.Sell0$0.000
Thu Mar 05Butler John P.director, officer: CEO and PresidentBuy69,270$1.253,367,064
Wed Feb 04Grund Nicholasofficer: Chief Commercial OfficerSell53,585$1.39592,994
Wed Feb 04Grund Nicholasofficer: Chief Commercial OfficerSell31,244$1.39561,750
Wed Feb 04Burke Steven Keithofficer: SVP, Chief Medical OfficerSell21,582$1.39994,508
Wed Feb 04Burke Steven Keithofficer: SVP, Chief Medical OfficerSell25,375$1.39969,133
Wed Feb 04Burke Steven Keithofficer: SVP, Chief Medical OfficerSell20,701$1.39948,432
Wed Feb 04Rucci Carolyn M.officer: SVP, Chief Legal OfficerSell16,846$1.39641,304
Wed Feb 04Rucci Carolyn M.officer: SVP, Chief Legal OfficerSell25,382$1.39615,922
Wed Feb 04Malabre Richard Cofficer: SVP, Chief Accounting OfficerSell13,382$1.39299,390
Wed Feb 04Malabre Richard Cofficer: SVP, Chief Accounting OfficerSell36,142$1.39312,772